Trials / Active Not Recruiting
Active Not RecruitingNCT06142201
A Real-World Study of JT001 for COVID-19
A Real-world Study：Disease Outcome and Safety of JT001 in Patients With Coronavirus Disease 2019 (COVID-19)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,656 (actual)
- Sponsor
- Shanghai Vinnerna Biosciences Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Real-world disease outcomes and safety in patients with mild to moderate COVID-19 treated with JT001
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JT001 | oral administration |
Timeline
- Start date
- 2023-08-31
- Primary completion
- 2024-11-30
- Completion
- 2024-12-31
- First posted
- 2023-11-21
- Last updated
- 2024-08-26
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06142201. Inclusion in this directory is not an endorsement.